INTRODUCTION OF CONTROLLED SUBSTANCES EXPORT REFORM ACT-HON. JOSEPH R. PITTS (Extensions of Remarks - July 21, 2004)
Mr. PITTS. Mr. Speaker, today I am introducing The Controlled Substances Export Reform Act, legislation to create and maintain U.S. jobs by reforming our Nation's outdated pharmaceutical export control laws.
Current law allows U.S. companies to export most controlled substances only to the immediate country where the products will be consumed. Shipment to central sites for further distribution across national boundaries is prohibited.
Mr. Speaker, foreign competitors labor under no such restrictions and can readily move approved medical products between international drug control treaty countries without limit or restriction. The exclusive prohibitions imposed by U.S. law on American manufacturers place them at significant disadvantage in international markets, creating powerful incentives for domestic companies to move production overseas, damaging local economies and costing U.S. jobs.
The legislation I have introduced today, along with a bipartisan group of my colleagues, authorizes the Attorney General to permit carefully regulated pharmaceutical exports to our international drug convention partner countries.
The bill retains full Drug Enforcement Administration (DEA) authority over all shipments of controlled substances and establishes strict procedures to ensure these products are used solely for legitimate medical purposes. While the DEA's authority over exports is undiminished, by creating new parity for U.S. companies with their international competitors, the legislation encourages domestic production and job growth.
The Controlled Substances Export Reform Act supports American jobs and protects U.S. interests. I look forward to working with my colleagues to enact this important legislation.